Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN

[1]  I. W. Cheney,et al.  Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. , 1998, Cancer research.

[2]  M. Wigler,et al.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Bigner,et al.  Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity. , 2005, Cancer research.

[4]  Tom Misteli,et al.  Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression , 2007, Cell.

[5]  William R. Sellers,et al.  Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein Complex* , 2001, The Journal of Biological Chemistry.

[6]  M. Peschanski,et al.  Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysis. , 2002, Journal of neurosurgery.

[7]  Pier Paolo Pandolfi,et al.  Tenets of PTEN Tumor Suppression , 2008, Cell.

[8]  Francisca Vazquez,et al.  Novel Mechanism of PTEN Regulation by Its Phosphatidylinositol 4,5-Bisphosphate Binding Motif Is Critical for Chemotaxis* , 2004, Journal of Biological Chemistry.

[9]  C. Moskaluk,et al.  PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity , 2004, Oncogene.

[10]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[11]  Helene Maccario,et al.  PTEN is destabilized by phosphorylation on Thr366. , 2007, The Biochemical journal.

[12]  A. Andres-Pons,et al.  Nuclear PTEN: a tale of many tails , 2007, Cell Death and Differentiation.

[13]  Cornelis J. Weijer,et al.  PtdIns(3,4,5)P3-Dependent and -Independent Roles for PTEN in the Control of Cell Migration , 2007, Current Biology.

[14]  R. Parsons,et al.  The role of PTEN signaling perturbations in cancer and in targeted therapy , 2008, Oncogene.

[15]  R. DePinho,et al.  Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[17]  C. Downes,et al.  A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic β‐cells , 2006, The EMBO journal.

[18]  G. Mills,et al.  Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. , 1998, Cancer research.

[19]  C. Downes,et al.  PTEN M-CBR3, a Versatile and Selective Regulator of Inositol 1,3,4,5,6-Pentakisphosphate (Ins(1,3,4,5,6)P5) , 2004, Journal of Biological Chemistry.

[20]  G. Adler,et al.  TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN , 2005, Journal of Cell Science.

[21]  R. Parsons,et al.  The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. , 2008, Cancer research.

[22]  A. Reymond,et al.  The TPTE gene family: cellular expression, subcellular localization and alternative splicing. , 2003, Gene.

[23]  M. Wigler,et al.  P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  AC Tose.  Cell , 1993, Cell.

[25]  W. Cavenee,et al.  Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  F. Cosset,et al.  Continuous high-titer HIV-1 vector production , 2003, Nature Biotechnology.

[27]  S. Park,et al.  PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. , 2002, Cancer research.

[28]  Tomohiko Maehama,et al.  Crystal Structure of the PTEN Tumor Suppressor Implications for Its Phosphoinositide Phosphatase Activity and Membrane Association , 1999, Cell.

[29]  Wonhwa Cho,et al.  Membrane-binding and activation mechanism of PTEN , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Cornelis J Weijer,et al.  Cell movement patterns during gastrulation in the chick are controlled by positive and negative chemotaxis mediated by FGF4 and FGF8. , 2002, Developmental cell.

[31]  R. B. Campbell,et al.  Allosteric Activation of PTEN Phosphatase by Phosphatidylinositol 4,5-Bisphosphate* , 2003, Journal of Biological Chemistry.

[32]  P. Pandolfi,et al.  Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.

[33]  Kenneth M. Yamada,et al.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.

[34]  Kenneth M. Yamada,et al.  Shc and Fak Differentially Regulate Cell Motility and Directionality Modulated by Pten , 1999, The Journal of cell biology.

[35]  William R Sellers,et al.  The biology and clinical relevance of the PTEN tumor suppressor pathway. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  C. Glover,et al.  Gene expression profiling for hematopoietic cell culture , 2006 .

[37]  Hong Wu,et al.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. , 2003, Cancer cell.

[38]  I. Batty,et al.  Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling , 2007, Oncogene.

[39]  W. Cavenee,et al.  The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. , 1998, Cancer research.

[40]  A. Gericke,et al.  PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes. , 2008, Biochemistry.

[41]  I. Batty,et al.  Understanding PTEN regulation: PIP2, polarity and protein stability , 2008, Oncogene.

[42]  Ian Pass,et al.  Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids. , 2003, The Biochemical journal.

[43]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[44]  S. Baker,et al.  PTEN function in normal and neoplastic growth. , 2006, Cancer letters.

[45]  T. Mak,et al.  Portrait of PTEN: Messages from mutant mice , 2008, Cancer science.

[46]  A. Hall,et al.  Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN , 2004, Science.

[47]  M. Sulis,et al.  Physiological levels of PTEN control the size of the cellular Ins(1,3,4,5,6)P(5) pool. , 2006, Cellular signalling.

[48]  J. Tonn,et al.  ECM‐mediated glioma cell invasion , 1998, Microscopy research and technique.

[49]  I. Batty,et al.  The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. , 2004, The Biochemical journal.

[50]  C. Downes,et al.  TPIP: a novel phosphoinositide 3-phosphatase. , 2001, The Biochemical journal.

[51]  L. Mahimainathan,et al.  Inactivation of Platelet-derived Growth Factor Receptor by the Tumor Suppressor PTEN Provides a Novel Mechanism of Action of the Phosphatase* , 2004, Journal of Biological Chemistry.

[52]  Q. Wan,et al.  Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse , 2006, Nature Medicine.

[53]  Henric Olsson,et al.  Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. , 2003, Analytical biochemistry.